Response to Stacey and Moller's letter to the editor
- PMID: 24090992
- PMCID: PMC4161205
- DOI: 10.1016/j.jpain.2013.07.003
Response to Stacey and Moller's letter to the editor
Conflict of interest statement
The authors have no conflicts of interest to report.
Comment on
-
Low-dose vaporized cannabis significantly improves neuropathic pain.J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009. Epub 2012 Dec 11. J Pain. 2013. PMID: 23237736 Free PMC article. Clinical Trial.
-
Marijuana for pain relief: don't jump to conclusions.J Pain. 2013 Oct;14(10):1250-1. doi: 10.1016/j.jpain.2013.07.002. J Pain. 2013. PMID: 24090991 No abstract available.
References
-
- Amadio P. Council on Science and Public Health Report 14 3 Use of Cannabis for Medicinal Purposes House of Delegates (I-09) Report of Reference Committee K, American Medical Association. 2009:12–14. www.ama-assn.org/assets/meeting/mm/i-09-ref-comm-k.pdf. Accessed May 9, 2013.
-
- Center for Drug Evaluation and Research. Guidance for Industry, Assessment of Abuse Potential of Drugs, U.S. Department of Health and Human Services Food and Drug Administration. 2010 Jan; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... Accessed May 9, 2013.
-
- Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–251. - PubMed
-
- Hoffmann DE, Weber E. Medical marijuana and the Law. N Engl J Med. 2010;362:1453–1457. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical